Stay updated with breaking news from Patrickr Oneil. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com upgraded shares of Ionis Pharmaceuticals (NASDAQ:IONS – Get Rating) from a hold rating to a buy rating in a research report report published on Thursday morning. Several other equities research analysts also recently weighed in on IONS. Bank of America downgraded shares of Ionis Pharmaceuticals from a buy rating to an underperform rating and […]
Ionis Pharmaceuticals (NASDAQ:IONS – Get Rating) was upgraded by stock analysts at TheStreet from a “d+” rating to a “c-” rating in a note issued to investors on Wednesday, TheStreetRatingsTable reports. A number of other brokerages have also recently weighed in on IONS. Guggenheim started coverage on shares of Ionis Pharmaceuticals in a research note […]
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) – Investment analysts at Oppenheimer decreased their Q1 2022 earnings per share estimates for shares of Ionis Pharmaceuticals in a research note issued to investors on Monday, April 18th. Oppenheimer analyst K. Degeeter now anticipates that the company will post earnings of ($0.75) per share for the quarter, […]